Procurement for medicinal products including generics, branded generics, and proprietary pharmaceuticals under Group 18 classification.
NHS is establishing a branded medicines framework agreement across English regions, with two separate lots for different geographical areas and contract durations starting September 2026.
NHS is seeking suppliers for a national two-year framework agreement to provide Lenalidomide, Pomalidomide, and Thalidomide across all English regions, with potential extensions up to 48 months.
